Abstract
Serum and CSF specimens of 30 MS patients and 30 age- and sex-matched control patients with other neurological diseases were tested for autoantibodies. Indirect immunofluorescense was used to detect smooth muscle antibodies and antinuclear antibodies in the serum. Antibodies against DNA and RNA in the serum and CSF were tested by solid phase radioimmunoassays. No significant differences in autoantibody levels were found between MS and control patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
